APA (7th ed.) Citation

Quante, M., Erhardt, A., Schmitz, V., Caselmann, W., Sauerbruch, T., & Rabe, C. (2008). 403 TO RULE OUT HEPATOCELLULAR CARCINOMA IN HIGH RISK PATIENTS: A NOVEL INDEX FOR EXCLUDING HEPATOCELLULAR CARCINOMA IN CENTRAL EUROPEAN IN-PATIENTS WITH LIVER DISEASE. Journal of Hepatology, 48, S156. https://doi.org/10.1016/S0168-8278(08)60405-5

Chicago Style (17th ed.) Citation

Quante, M., A. Erhardt, V. Schmitz, W. Caselmann, T. Sauerbruch, and C. Rabe. "403 TO RULE OUT HEPATOCELLULAR CARCINOMA IN HIGH RISK PATIENTS: A NOVEL INDEX FOR EXCLUDING HEPATOCELLULAR CARCINOMA IN CENTRAL EUROPEAN IN-PATIENTS WITH LIVER DISEASE." Journal of Hepatology 48 (2008): S156. https://doi.org/10.1016/S0168-8278(08)60405-5.

MLA (9th ed.) Citation

Quante, M., et al. "403 TO RULE OUT HEPATOCELLULAR CARCINOMA IN HIGH RISK PATIENTS: A NOVEL INDEX FOR EXCLUDING HEPATOCELLULAR CARCINOMA IN CENTRAL EUROPEAN IN-PATIENTS WITH LIVER DISEASE." Journal of Hepatology, vol. 48, 2008, p. S156, https://doi.org/10.1016/S0168-8278(08)60405-5.